中国医院用药评价与分析Issue(10)：1419-1421,1422,4.DOI:10.14009/j.issn.1672-2124.2015.10.048
1例结肠癌患者应用西妥昔单抗后出现严重痤疮样皮疹的药学监护
Pharmaceutical Care for One Colon Cancer Patient with Severe Acneiform Rash after the Treatment of Cetuximab
孔树佳 1李砚文2
作者信息
- 1. 昆明医科大学第三附属医院·云南省肿瘤医院药剂科，云南昆明 650118
- 2. 昆明医科大学第三附属医院·云南省肿瘤医院重症医学科，云南昆明 650118
- 折叠
摘要
Abstract
OBJECTIVE:To probe into the entry point of pharmaceutical care for one colorectal liver metastases patient with severe acneiform rash after the treatment of cetuximab combined with chemotherapy FOLFIRINOX. METHODS:Clinical pharmacists participated in the whole course of the patient's therapeutic regimen,and analyzed the cause of acne and application of acne medication then provided pharmaceutical care for the patient.RESULTS:With the analysis of clinical pharmacists, acneiform rash was turned out to be the adverse reactions induced by cetuximab combined with chemotherapy FOLFIRINOX.The clinicians were advised to use mupirocin and cefaclor as expectant treatment,which released the effect of acneiform rash on the patients with continuously application of cetuximab treatment and ensured the patients could receive enough treatment course,avoid delay of the disease.CONCLUSIONS:The clinical pharmacists go into the clinic to develop pharmaceutical care can assist the clinicians with safety and effective medication,and avoid or reduce the incidence of adverse drug reactions.关键词
西妥昔单抗/痤疮样皮疹/药学监护Key words
Cetuximab/Acneiform rash/Pharmaceutical care分类
医药卫生引用本文复制引用
孔树佳,李砚文..1例结肠癌患者应用西妥昔单抗后出现严重痤疮样皮疹的药学监护[J].中国医院用药评价与分析,2015,(10):1419-1421,1422,4.
